Current trends in advanced therapy development & commercialization for rare diseases

On January 26th 2023, David McCall, Commissioning Editor, Cell & Gene Therapy Insights, spoke to Alan Boyd, CEO & Founder of Boyds, about gene therapy trends and innovation in the rare and ultra-rare diseases space. This viewpoint has been written based on that interview.

“Since those early days, financing has increased in the gene therapy space, with the commercial advances that have followed resulting in multiple product approvals, mainly in rare diseases, both in North America and Europe.”

Please enter your email to access content Read now